Day One Biopharmaceuticals Delisted from Nasdaq

Ticker: DAWN · Form: 25-NSE · Filed: Apr 23, 2026 · CIK: 0001845337

Sentiment: neutral

Topics: delisting, sec-filing, biotech

Related Tickers: DAYO

TL;DR

Day One Bio is officially off Nasdaq as of 4/23/26.

AI Summary

Nasdaq Stock Market LLC filed a Form 25-NSE on April 23, 2026, to report the removal from listing and registration of securities for Day One Biopharmaceuticals, Inc. This action is typically taken when securities have been matured, redeemed, or retired.

Why It Matters

This filing indicates that Day One Biopharmaceuticals' securities are no longer listed on the Nasdaq exchange, which could impact liquidity and investor access.

Risk Assessment

Risk Level: medium — Delisting can signal financial distress or significant corporate changes, impacting investor confidence and stock accessibility.

Key Players & Entities

FAQ

What is the specific reason for the removal of Day One Biopharmaceuticals' securities from listing?

The filing states the removal is for 'matured, redeemed or retired securities', but does not provide further specific details on the event.

When was the Form 25-NSE filed?

The Form 25-NSE was filed on April 23, 2026.

What is the CIK for Day One Biopharmaceuticals, Inc.?

The CIK for Day One Biopharmaceuticals, Inc. is 0001845337.

What is the CIK for Nasdaq Stock Market LLC?

The CIK for Nasdaq Stock Market LLC is 0001354457.

What is the file number for Day One Biopharmaceuticals, Inc. on the SEC?

The file number for Day One Biopharmaceuticals, Inc. is 001-40431.

Filing Details

This Form 25-NSE (Form 25-NSE) was filed with the SEC on April 23, 2026 regarding Day One Biopharmaceuticals, Inc. (DAWN).

View full filing on EDGAR

View Full Filing

View this 25-NSE filing on SEC EDGAR

View on Read The Filing